Literature DB >> 27766663

Effects of hydroxyurea on F-cells in sickle cell disease and potential impact of a second fetal globin inducer.

Yan Dai1,2, Jose Sangerman3, Mehdi Nouraie4, Aidan D Faller3, Patricia Oneal5, Angela Rock5, Oluwakemi Owoyemi5, Xiaomei Niu5, Sergei Nekhai5, Dashmeet Maharaj3, Shauiying Cui6, Robert Taylor5, Martin Steinberg6,7, Susan Perrine1,2,3,5,8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27766663      PMCID： PMC5167623          DOI： 10.1002/ajh.24590

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  6 in total

1.  The effect of fetal hemoglobin on the survival characteristics of sickle cells.

Authors:  Robert S Franco; Zahida Yasin; Mary B Palascak; Peter Ciraolo; Clinton H Joiner; Donald L Rucknagel
Journal:  Blood       Date:  2006-08-01       Impact factor: 22.113

2.  High prevalence of individuals with low concentration of fetal hemoglobin in F-cells in sickle cell anemia in Tanzania.

Authors:  Florence Urio; Magdalena Lyimo; Siana Nkya Mtatiro; Sharon E Cox; Bruno P Mmbando; Julie Makani
Journal:  Am J Hematol       Date:  2016-05-11       Impact factor: 10.047

3.  The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up.

Authors:  Martin H Steinberg; William F McCarthy; Oswaldo Castro; Samir K Ballas; F Danny Armstrong; Wally Smith; Kenneth Ataga; Paul Swerdlow; Abdullah Kutlar; Laura DeCastro; Myron A Waclawiw
Journal:  Am J Hematol       Date:  2010-06       Impact factor: 10.047

Review 4.  Targeted fetal hemoglobin induction for treatment of beta hemoglobinopathies.

Authors:  Susan P Perrine; Betty S Pace; Douglas V Faller
Journal:  Hematol Oncol Clin North Am       Date:  2014-04       Impact factor: 3.722

5.  Fetal hemoglobin in sickle cell anemia: a glass half full?

Authors:  Martin H Steinberg; David H K Chui; George J Dover; Paola Sebastiani; Abdulrahman Alsultan
Journal:  Blood       Date:  2013-11-12       Impact factor: 22.113

6.  Production of F cells in sickle cell anemia: regulation by a genetic locus or loci separate from the beta-globin gene cluster.

Authors:  S H Boyer; G J Dover; G R Serjeant; K D Smith; S E Antonarakis; S H Embury; L Margolet; A N Noyes; M L Boyer; W B Bias
Journal:  Blood       Date:  1984-11       Impact factor: 22.113
  6 in total
  5 in total

1.  BCL2L1 is associated with γ-globin gene expression.

Authors:  Yan Dai; Elmutaz M Shaikho; Jessica Perez; Carolyn A Wilson; Lesley Y Liu; Mitchell R White; John J Farrell; David H K Chui; Paola Sebastiani; Martin H Steinberg
Journal:  Blood Adv       Date:  2019-10-22

2.  Benserazide racemate and enantiomers induce fetal globin gene expression in vivo: Studies to guide clinical development for beta thalassemia and sickle cell disease.

Authors:  Betty S Pace; Susan Perrine; Biaoru Li; Levi Makala; Hongyan Xu; Mayuko Takezaki; Roman F Wolf; Amy Wang; Xin Xu; Junfeng Huang; Asaf Alimardanov; Gregory J Tawa; Jose Sangerman; Aidan Faller; Wei Zheng; London Toney; Sharie J Haugabook
Journal:  Blood Cells Mol Dis       Date:  2021-03-12       Impact factor: 2.372

3.  Trienone analogs of curcuminoids induce fetal hemoglobin synthesis via demethylation at Gγ-globin gene promoter.

Authors:  Khanita Nuamsee; Thipphawan Chuprajob; Wachirachai Pabuprapap; Pornrutsami Jintaridth; Thongperm Munkongdee; Phatchariya Phannasil; Jim Vadolas; Pornthip Chaichompoo; Apichart Suksamrarn; Saovaros Svasti
Journal:  Sci Rep       Date:  2021-04-20       Impact factor: 4.379

Review 4.  Pharmacological Induction of Fetal Hemoglobin in β-Thalassemia and Sickle Cell Disease: An Updated Perspective.

Authors:  Rayan Bou-Fakhredin; Lucia De Franceschi; Irene Motta; Maria Domenica Cappellini; Ali T Taher
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-16

5.  Early initiation of hydroxyurea (hydroxycarbamide) using individualised, pharmacokinetics-guided dosing can produce sustained and nearly pancellular expression of fetal haemoglobin in children with sickle cell anaemia.

Authors:  Charles T Quinn; Omar Niss; Min Dong; Amanda Pfeiffer; Jennifer Korpik; Mary Reynaud; Holly Bonar; Theodosia A Kalfa; Luke R Smart; Punam Malik; Russell E Ware; Alexander A Vinks; Patrick T McGann
Journal:  Br J Haematol       Date:  2021-07-05       Impact factor: 8.615
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.